Clinical Trial Update: Imaging in MGUS, SMM and MM [Phase 2]

View source ↗

Summary

Completed Phase 2 clinical trial evaluating imaging in monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and multiple myeloma; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma
• Smoldering Multiple Myeloma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Multiple Myeloma, Smoldering Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2015-01-16